Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
36 participants
INTERVENTIONAL
2017-05-01
2022-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Budesonide Via MAD or INSI Prospective Cohort Study
NCT04267042
Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis
NCT03705793
The Long-Term Safety of Budesonide for Patients With Chronic Rhinosinusitis
NCT03584178
Nebulized Nasal Steroids
NCT07270302
Efficacy of Budesonide Via Delayed Release vs Immediate Release
NCT04476628
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mometasone nasal spray
Mometasone nasal spray 50 mcg/dose, 2 sprays/nostril twice daily x 3 months Patients will also be taking Sinus Rinse once daily throughout the study period
Mometasone nasal spray
Mometasone 50 mcg/spray 2 sprays twice daily
Budesonide irrigation
2 cc budesonide nebule (0,5 mg/cc) incorporated to 240 of saline water (Sinus Rinse) to be taken on a daily basis x 3 months
Budesonide 0.5 MG/ML
2 cc nebule of budesonide in 240 cc of saline water (Sinus Rinse) once daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Budesonide 0.5 MG/ML
2 cc nebule of budesonide in 240 cc of saline water (Sinus Rinse) once daily
Mometasone nasal spray
Mometasone 50 mcg/spray 2 sprays twice daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Absence of active infection at start of study
Exclusion Criteria
* Diagnosis of recurrent acute bacterial rhinosinusitis
* Previous sinus surgery (septal of inferior turbinate surgeries are not considered sinus surgeries)
* Cystic fibrosis or ciliary dyskinesia
* Allergy to corticosteroids
* Pregnant or lactating women
* Contra-indication to intranasal steroids
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université de Sherbrooke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marie Bussières
Otolaryngologist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Université de Sherbrooke
Sherbrooke, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-1569
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.